{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:43:38Z","timestamp":1773243818110,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["2012-0059"],"award-info":[{"award-number":["2012-0059"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007351","name":"Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["20020120200050BA"],"award-info":[{"award-number":["20020120200050BA"]}],"id":[{"id":"10.13039\/501100007351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Mycobacterium tuberculosis<\/jats:italic> (<jats:italic>Mtb<\/jats:italic>) is the causative agent of tuberculosis (TB), affecting approximately one third of the world\u2019s population. Development of an adequate immune response will determine disease progression or progress to chronic infection. Risk of developing TB among human immunodeficiency virus (HIV)-coinfected patients (HIV-TB) is 20\u201330 times higher than those without HIV infection, and a synergistic interplay between these two pathogens accelerates the decline in immunological functions. TB treatment in HIV-TB coinfected persons is challenging and it has a prolonged duration, mainly due to the immune system failure to provide an adequate support for the therapy. Therefore, we aimed to study the role of the hormone 7-oxo-dehydroepiandrosterone (7-OD) as a modulator of anti-tuberculosis immune responses in the context of HIV-TB coinfection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was conducted among HIV-TB patients and healthy donors (HD). We characterized the ex vivo phenotype of CD4\u2009+\u2009T cells and also evaluated in vitro antigen-specific responses by <jats:italic>Mtb<\/jats:italic> stimulation of peripheral blood mononuclear cells (PBMCs) in the presence or absence of 7-OD. We assessed lymphoproliferative activity, cytokine production and master transcription factor profiles.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our results show that HIV-TB patients were not able to generate successful anti-tubercular responses in vitro compared to HD, as reduced IFN-\u03b3\/IL-10 and IFN-\u03b3\/IL-17A ratios were observed. Interestingly, treatment with 7-OD enhanced Th1 responses by increasing <jats:italic>Mtb<\/jats:italic>-induced proliferation and the production of IFN-\u03b3 and TNF-\u03b1 over IL-10 levels. Additionally, in vitro <jats:italic>Mtb<\/jats:italic> stimulation augmented the frequency of cells with a regulatory phenotype, while 7-OD reduced the proportion of these subsets and induced an increase in CD4\u2009+\u2009T-bet+ (Th1) subpopulation, which is associated with clinical data linked to an improved disease outcome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We conclude that 7-OD modifies the cytokine balance and the phenotype of CD4\u2009+\u2009T cells towards a more favorable profile for mycobacteria control. These results provide new data to delineate novel treatment approaches as co-adjuvant for the treatment of TB.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12929-019-0604-z","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T08:02:35Z","timestamp":1578297755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["7-oxo-DHEA enhances impaired M. tuberculosis-specific T cell responses during HIV-TB coinfection"],"prefix":"10.1186","volume":"27","author":[{"given":"Mar\u00eda Bel\u00e9n","family":"Vecchione","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Laufer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Sued","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Corti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horacio","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0956-5492","authenticated-orcid":false,"given":"Maria Florencia","family":"Quiroga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"issue":"11","key":"604_CR1","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1086\/593017","volume":"198","author":"Christof Geldmacher","year":"2008","unstructured":"Geldmacher C, Schuetz A, Ngwenyama N, Casazza JP, Sanga E, Saathoff E, et al. Early depletion of Mycobacterium tuberculosis \u2013specific T helper 1 cell responses after HIV-1 infection. J Infect Dis [Internet] 2008;198:1590\u20131598. Available from: https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/https:\/\/doi.org\/10.1086\/593017","journal-title":"The Journal of Infectious Diseases"},{"key":"604_CR2","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/S1473-3099(18)30110-5","volume":"18","author":"S Tiberi","year":"2018","unstructured":"Tiberi S, du Plessis N, Walzl G, Vjecha MJ, Rao M, Ntoumi F, et al. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect Dis [Internet]. 2018;18:e183\u201398 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473309918301105.","journal-title":"Lancet Infect Dis [Internet]"},{"key":"604_CR3","first-page":"e34","volume":"16","author":"RS Wallis","year":"2016","unstructured":"Wallis RS, Maeurer M, Mwaba P, Chakaya J, Rustomjee R, Migliori GB, et al. Tuberculosis\u2014advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. Lancet infect dis [Internet]. Elsevier Ltd. 2016;16:e34\u201346 Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1473309916000700.","journal-title":"Elsevier Ltd"},{"key":"604_CR4","doi-asserted-by":"crossref","unstructured":"Ernst JD. The immunological life cycle of tuberculosis. Nat Rev Immunol [Internet]. Nature Publishing Group; 2012 [cited 2013 Feb 28];12:581\u2013591. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22790178.","DOI":"10.1038\/nri3259"},{"issue":"1","key":"604_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-immunol-032414-112056","volume":"34","author":"Federica Sallusto","year":"2016","unstructured":"Sallusto F. Heterogeneity of human CD4 + T cells against microbes. Annu Rev Immunol [Internet] 2016;34:317\u2013334. Available from: http:\/\/www.annualreviews.org\/doi\/https:\/\/doi.org\/10.1146\/annurev-immunol-032414-112056","journal-title":"Annual Review of Immunology"},{"issue":"6","key":"604_CR6","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","volume":"178","author":"J L Flynn","year":"1993","unstructured":"Flynn JL. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med [Internet]. 1993;178:2249\u20132254. Available from: http:\/\/www.jem.org\/cgi\/doi\/https:\/\/doi.org\/10.1084\/jem.178.6.2249","journal-title":"The Journal of Experimental Medicine"},{"key":"604_CR7","first-page":"1","volume":"2015","author":"M Vinicius","year":"2015","unstructured":"Vinicius M, Gomes M, Tiburcio S, Machado JR, Alexandre D, Silva A, et al. Complexity and controversies over the cytokine profiles of T helper cell subpopulations in Tuberculosis. J Immunol Res. 2015;2015:1\u201313.","journal-title":"J Immunol Res"},{"issue":"1","key":"604_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/sj.jidsymp.5650027","volume":"12","author":"Philana Ling Lin","year":"2007","unstructured":"Lin PL, Plessner HL, Voitenok NN, Flynn JL. Tumor necrosis factor and tuberculosis. J Investig dermatology Symp Proc [Internet]. Elsevier Masson SAS; 2007;12:22\u201325. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1038\/sj.jidsymp.5650027","journal-title":"Journal of Investigative Dermatology Symposium Proceedings"},{"issue":"suppl_4","key":"604_CR9","doi-asserted-by":"publisher","first-page":"iv24","DOI":"10.1136\/ard.2005.042531","volume":"64","author":"S Stenger","year":"2005","unstructured":"Stenger S. Immunological control of tuberculosis: role of tumour necrosis factor and more. Ann Rheum Dis [Internet]. 2005;64:iv24\u2013iv28. Available from: http:\/\/ard.bmj.com\/cgi\/doi\/https:\/\/doi.org\/10.1136\/ard.2005.042531","journal-title":"Annals of the Rheumatic Diseases"},{"key":"604_CR10","doi-asserted-by":"crossref","unstructured":"Philips J A, Ernst JD. Tuberculosis pathogenesis and immunity. Annu Rev Pathol [Internet]. 2012 [cited 2013 mar 7];7:353\u2013384. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22054143.","DOI":"10.1146\/annurev-pathol-011811-132458"},{"key":"604_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ejps.2014.05.028","volume":"62","author":"Neeraj K. Garg","year":"2014","unstructured":"Garg NK, Dwivedi P, Jain A, Tyagi S, Sahu T, Tyagi RK. Development of novel carrier(s) mediated tuberculosis vaccine: more than a tour de force. Eur J Pharm Sci [Internet]. Elsevier B.V.; 2014 [cited 2015 mar 10];62:227\u201342. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24909731.","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"8","key":"604_CR12","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.4049\/jimmunol.0903332","volume":"184","author":"Yuko Okamoto Yoshida","year":"2010","unstructured":"Okamoto Yoshida Y, Umemura M, Yahagi A, O\u2019Brien RL, Ikuta K, Kishihara K, et al. Essential Role of IL-17A in the Formation of a Mycobacterial Infection-Induced Granuloma in the Lung. J Immunol [Internet]. 2010;184:4414\u20134422. Available from: http:\/\/www.jimmunol.org\/cgi\/doi\/https:\/\/doi.org\/10.4049\/jimmunol.0903332","journal-title":"The Journal of Immunology"},{"issue":"8","key":"604_CR13","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1084\/jem.20100265","volume":"207","author":"Andrea Cruz","year":"2010","unstructured":"Cruz A, Fraga AG, Fountain JJ, Rangel-Moreno J, Torrado E, Saraiva M, et al. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med [Internet]. 2010;207:1609\u20131616. Available from: http:\/\/www.jem.org\/lookup\/doi\/https:\/\/doi.org\/10.1084\/jem.20100265","journal-title":"The Journal of Experimental Medicine"},{"key":"604_CR14","doi-asserted-by":"crossref","unstructured":"Suarez GV, Vecchione MB, Angerami MT, Sued O, Bruttomesso AC, Bottasso OA, et al. Immunoendocrine interactions during HIV-TB coinfection : implications for the design of new adjuvant therapies. Biomed Res Int. 2015;2015.","DOI":"10.1155\/2015\/461093"},{"issue":"7","key":"604_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/intimm\/dxt004","volume":"25","author":"Matias Angerami","year":"2013","unstructured":"Angerami M, Suarez G, Pascutti MF, Salomon H, Bottasso O, Quiroga MF. Modulation of the phenotype and function of Mycobacterium tuberculosis-stimulated dendritic cells by adrenal steroids. Int Immunol [Internet]. 2013 [cited 2014 may 26];25:405\u2013411. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23446847.","journal-title":"International Immunology"},{"key":"604_CR16","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/eji.201545545","volume":"45","author":"GV Suarez","year":"2015","unstructured":"Suarez GV, Angerami MT, Vecchione MB, Laufer N, Turk G, Ruiz MJ, et al. HIV\u2013TB coinfection impairs CD8+ T-cell differentiation and function while dehydroepiandrosterone improves cytotoxic antitubercular immune responses. Eur J Immunol. 2015;45:2529\u201341.","journal-title":"Eur J Immunol"},{"key":"604_CR17","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1038\/s41598-018-24771-8","volume":"8","author":"MB Vecchione","year":"2018","unstructured":"Vecchione MB, Eiras J, Suarez GV, Angerami MT, Marquez C, Sued O, et al. Determination of dehydroepiandrosterone and its biologically active oxygenated metabolites in human plasma evinces a hormonal imbalance during HIV-TB coinfection. Sci Rep [Internet]. 2018;8:6692 Available from: http:\/\/www.nature.com\/articles\/s41598-018-24771-8.","journal-title":"Sci Rep [Internet]"},{"key":"604_CR18","unstructured":"Department of Health and Human Services. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. [Internet]. 2018. Available from: http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/ AdultandAdolescentGL.pdf. Accessed."},{"issue":"3","key":"604_CR19","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.4049\/jimmunol.177.3.1416","volume":"177","author":"Andrea Cruz","year":"2006","unstructured":"Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J, et al. Cutting Edge: IFN- Regulates the Induction and Expansion of IL-17-Producing CD4 T Cells during Mycobacterial Infection. J Immunol [Internet]. 2006;177:1416\u20131420. Available from: http:\/\/www.jimmunol.org\/cgi\/doi\/https:\/\/doi.org\/10.4049\/jimmunol.177.3.1416","journal-title":"The Journal of Immunology"},{"issue":"12","key":"604_CR20","doi-asserted-by":"publisher","first-page":"6954","DOI":"10.1128\/IAI.68.12.6954-6961.2000","volume":"68","author":"L.-G. Bekker","year":"2000","unstructured":"Bekker L-G, Moreira AL, Bergtold A, Freeman S, Ryffel B, Kaplan G. Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect Immun [Internet] 2000;68:6954\u20136961. Available from: http:\/\/iai.asm.org\/cgi\/doi\/https:\/\/doi.org\/10.1128\/IAI.68.12.6954-6961.2000","journal-title":"Infection and Immunity"},{"issue":"6","key":"604_CR21","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"E John Wherry","year":"2011","unstructured":"Wherry EJ. T cell exhaustion. Nat Immunol [Internet]. Nature publishing group; 2011;12:492\u2013499. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21739672.","journal-title":"Nature Immunology"},{"issue":"20","key":"604_CR22","doi-asserted-by":"publisher","first-page":"10900","DOI":"10.1128\/JVI.77.20.10900-10909.2003","volume":"77","author":"C. Iyasere","year":"2003","unstructured":"Iyasere C, Tilton JC, Johnson AJ, Younes S, Yassine-Diab B, Sekaly R-P, et al. Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2. J Virol [Internet]. 2003;77:10900\u201310909. Available from: http:\/\/jvi.asm.org\/cgi\/doi\/https:\/\/doi.org\/10.1128\/JVI.77.20.10900-10909.2003","journal-title":"Journal of Virology"},{"issue":"1","key":"604_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2015.04.002","volume":"159","author":"S. Siddiqui","year":"2015","unstructured":"Siddiqui S, Sarro Y, Diarra B, Diallo H, Guindo O, Dabitao D, et al. Tuberculosis specific responses following therapy for TB: Impact of HIV co-infection. Clin Immunol [Internet]. Elsevier B.V.; 2015;159:1\u201312. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.clim.2015.04.002","journal-title":"Clinical Immunology"},{"key":"604_CR24","doi-asserted-by":"crossref","unstructured":"Lyadova I V., Panteleev A V. Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers. Mediators Inflamm. Hindawi Publishing Corporation; 2015;2015.","DOI":"10.1155\/2015\/854507"},{"key":"604_CR25","doi-asserted-by":"crossref","unstructured":"Quiroga MF, Angerami MT, Santucci N, Ameri D, Francos JL, Wallach J, et al. Dynamics of adrenal steroids are related to variations in Th1 and Treg populations during Mycobacterium tuberculosis infection in HIV positive persons. PLoS One [Internet]. 2012 [cited 2013 Mar 13];7:e33061. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3303789&tool=pmcentrez&rendertype=abstract","DOI":"10.1371\/journal.pone.0033061"},{"key":"604_CR26","doi-asserted-by":"crossref","unstructured":"Angerami MT, Suarez GV, Vecchione MB, Laufer N, Ameri D, Ben G, et al. Expansion of CD25-negative forkhead box P3-positive T cells during HIV and mycobacterium tuberculosis infection. Front Immunol. 2017.","DOI":"10.3389\/fimmu.2017.00528"},{"key":"604_CR27","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.4049\/jimmunol.1502094","volume":"196","author":"C Riou","year":"2016","unstructured":"Riou C, Strickland N, Soares AP, Corleis B, Kwon DS, Wherry EJ, et al. HIV skews the lineage-defining transcriptional profile of Mycobacterium tuberculosis-specific CD4+ T cells. J Immunol. 2016;196:3006\u201318.","journal-title":"J Immunol"},{"key":"604_CR28","first-page":"1122","volume":"5","author":"CF Von Reyn","year":"2001","unstructured":"Von Reyn CF, Horsburgh CR, Olivier KN, Barnes PF, Waddell R, Warren C, et al. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States SUMMARY. Int J Tuberc Lung Dis. 2001;5:1122\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"604_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1086\/524685","volume":"197","author":"Abdulrahman\u00a0S. Hammond","year":"2008","unstructured":"Hammond AS, McConkey SJ, Hill PC, Crozier S, Klein MR, Adegbola RA, et al. Mycobacterial T Cell Responses in HIV-Infected Patients with Advanced Immunosuppression. J Infect Dis [Internet]. 2008;197:295\u2013299. Available from: https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/https:\/\/doi.org\/10.1086\/524685","journal-title":"The Journal of Infectious Diseases"},{"issue":"6","key":"604_CR30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.0300-9475.2004.01514.x","volume":"60","author":"C. Mahuad","year":"2004","unstructured":"Mahuad C, Bay ML, Farroni MA, Bozza V, Del Rey A, Besedovsky H, et al. Cortisol and Dehydroepiandrosterone affect the response of peripheral blood mononuclear cells to mycobacterial antigens during Tuberculosis. Scand J Immunol [Internet] 2004;60:639\u2013646. Available from: http:\/\/doi.wiley.com\/https:\/\/doi.org\/10.1111\/j.0300-9475.2004.01514.x","journal-title":"Scandinavian Journal of Immunology"},{"issue":"10","key":"604_CR31","doi-asserted-by":"publisher","first-page":"e46481","DOI":"10.1371\/journal.pone.0046481","volume":"7","author":"Keira H. Skolimowska","year":"2012","unstructured":"Skolimowska KH, Rangaka MX, Meintjes G, Pepper DJ, Seldon R, Matthews K, et al. Altered Ratio of IFN-\u03b3\/IL-10 in Patients with Drug Resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome. Hoshino Y, editor. PLoS One [Internet]. 2012;7:e46481. Available from: https:\/\/dx.plos.org\/https:\/\/doi.org\/10.1371\/journal.pone.0046481","journal-title":"PLoS ONE"},{"key":"604_CR32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.semarthrit.2003.11.002","volume":"33","author":"D G\u00f3mez","year":"2004","unstructured":"G\u00f3mez D, Correa PA, G\u00f3mez LM, Cadena J, Molina JF, Anaya J-M. Th1\/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor \u03b1 protective? Semin Arthritis Rheum [Internet]. 2004;33:404\u201313 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017203002142.","journal-title":"Semin Arthritis Rheum [Internet]"},{"issue":"2","key":"604_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jinf.2015.04.032","volume":"71","author":"Maddineni Prabhavathi","year":"2015","unstructured":"Prabhavathi M, Pathakumari B, Raja A. IFN-\u03b3\/TNF-\u03b1 ratio in response to immuno proteomically identified human T-cell antigens of Mycobacterium tuberculosis \u2013 the most suitable surrogate biomarker for latent TB infection. J infect [Internet]. Elsevier Ltd; 2015;71:238\u2013249. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.jinf.2015.04.032","journal-title":"Journal of Infection"},{"key":"604_CR34","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.4049\/jimmunol.178.6.3786","volume":"178","author":"M Umemura","year":"2014","unstructured":"Umemura M, Yahagi A, Hamada S, Begum MD, Watanabe H, Kawakami K, et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis Bacille Calmette-Guerin infection. J Immunol. 2014;178:3786\u201396.","journal-title":"J Immunol"},{"key":"604_CR35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ni1449","volume":"8","author":"SA Khader","year":"2007","unstructured":"Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol [Internet]. 2007;8:369\u201377 Available from: http:\/\/www.nature.com\/articles\/ni1449.","journal-title":"Nat Immunol [Internet]"},{"issue":"7","key":"604_CR36","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.4049\/jimmunol.1502094","volume":"196","author":"Catherine Riou","year":"2016","unstructured":"Riou C, Strickland N, Soares AP, Corleis B, Kwon DS, Wherry EJ, et al. HIV skews the lineage-defining transcriptional profile of Mycobacterium tuberculosis \u2013specific CD4 + T cells. J Immunol [Internet]. 2016;196:3006\u20133018. Available from: http:\/\/www.jimmunol.org\/lookup\/doi\/https:\/\/doi.org\/10.4049\/jimmunol.1502094","journal-title":"The Journal of Immunology"},{"key":"604_CR37","doi-asserted-by":"publisher","unstructured":"Angerami MT, Suarez G V., Vecchione MB, Laufer N, Ameri D, Ben G, et al. Expansion of CD25-Negative Forkhead Box P3-Positive T Cells during HIV and Mycobacterium tuberculosis Infection. Front Immunol [Internet]. 2017;8. Available from: http:\/\/journal.frontiersin.org\/article\/https:\/\/doi.org\/10.3389\/fimmu.2017.00528\/full","DOI":"10.3389\/fimmu.2017.00528\/full"},{"key":"604_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.clim.2006.11.009","volume":"123","author":"X Chen","year":"2007","unstructured":"Chen X, Zhou B, Li M, Deng Q, Wu X, Le X, et al. CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol. 2007;123:50\u20139.","journal-title":"Clin Immunol"},{"issue":"6","key":"604_CR39","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.smim.2014.10.003","volume":"26","author":"Kevin B. Urdahl","year":"2014","unstructured":"Urdahl KB. Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis. Semin Immunol [Internet]. Elsevier Ltd; 2014;26:578\u2013587. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.smim.2014.10.003","journal-title":"Seminars in Immunology"},{"issue":"1","key":"604_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2249.2006.03027.x","volume":"144","author":"R. Ribeiro-Rodrigues","year":"2006","unstructured":"Ribeiro-Rodrigues R, Resende Co T, Rojas R, Toossi Z, Dietze R, Boom WH, et al. A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol [Internet] 2006;144:25\u201334. Available from: http:\/\/doi.wiley.com\/https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03027.x","journal-title":"Clinical and Experimental Immunology"},{"key":"604_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","volume":"32","author":"AO Garra","year":"2013","unstructured":"Garra AO, Redford PS, Mcnab FW, Bloom CI, Wilkinson RJ, Berry MPR. The immune response in Tuberculosis. Annu Rev Immunol. 2013;32:475\u2013527.","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"604_CR42","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1084\/jem.20080034","volume":"205","author":"Matthias Lochner","year":"2008","unstructured":"Lochner M, Peduto L, Cherrier M, Sawa S, Langa F, Varona R, et al. In vivo equilibrium of proinflammatory IL-17 + and regulatory IL-10 + Foxp3 + ROR\u03b3t + T cells. J Exp Med [Internet] 2008;205:1381\u20131393. Available from: http:\/\/www.jem.org\/lookup\/doi\/https:\/\/doi.org\/10.1084\/jem.20080034","journal-title":"The Journal of Experimental Medicine"},{"issue":"7","key":"604_CR43","doi-asserted-by":"publisher","first-page":"e1004251","DOI":"10.1371\/journal.ppat.1004251","volume":"10","author":"Marcus Buggert","year":"2014","unstructured":"Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson MA, Micha\u00eblsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014;10.","journal-title":"PLoS Pathogens"},{"key":"604_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2014.00217","volume":"5","author":"JJ Knox","year":"2014","unstructured":"Knox JJ, Cosma GL, Betts MR, McLane LM. Characterization of T-bet and Eomes in peripheral human immune cells. Front Immunol. 2014;5:1\u201313.","journal-title":"Front Immunol"},{"issue":"1","key":"604_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1086\/648735","volume":"201","author":"Subash Babu","year":"2010","unstructured":"Babu S, Bhat SQ, Kumar NP, Kumaraswami V, Nutman TB. Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results. J Infect Dis [Internet]. 2010;201:20\u201331. Available from: https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/https:\/\/doi.org\/10.1086\/648735","journal-title":"The Journal of Infectious Diseases"},{"issue":"2","key":"604_CR46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00109-011-0816-5","volume":"90","author":"Chun Zeng","year":"2011","unstructured":"Zeng C, Shi X, Zhang B, Liu H, Zhang L, Ding W, et al. The imbalance of Th17\/Th1\/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med [Internet] 2012;90:175\u2013186. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00109-011-0816-5","journal-title":"Journal of Molecular Medicine"},{"issue":"12","key":"604_CR47","doi-asserted-by":"publisher","first-page":"6586","DOI":"10.1128\/JVI.06251-11","volume":"86","author":"D. S. Kwon","year":"2012","unstructured":"Kwon DS, Angin M, Hongo T, Law KM, Johnson J, Porichis F, et al. CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by Upregulating Interleukin-10 production in monocytes. J Virol [Internet] 2012;86:6586\u20136594. Available from: http:\/\/jvi.asm.org\/cgi\/doi\/https:\/\/doi.org\/10.1128\/JVI.06251-11","journal-title":"Journal of Virology"},{"key":"604_CR48","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nbt.3187","volume":"33","author":"L Lin","year":"2015","unstructured":"Lin L, Finak G, Ushey K, Seshadri C, Hawn TR, Frahm N, et al. COMPASS identifies T-cell subsets correlated with clinical outcomes. Nat Biotechnol [Internet]. 2015;33:610\u20136 Available from: http:\/\/www.nature.com\/articles\/nbt.3187.","journal-title":"Nat Biotechnol [Internet]"},{"key":"604_CR49","doi-asserted-by":"publisher","first-page":"11948","DOI":"10.1038\/s41598-017-10773-5","volume":"7","author":"S Rakshit","year":"2017","unstructured":"Rakshit S, Adiga V, Nayak S, Sahoo PN, Sharma PK, van Meijgaarden KE, et al. Circulating Mycobacterium tuberculosis DosR latency antigen-specific, polyfunctional, regulatory IL10+ Th17 CD4 T-cells differentiate latent from active tuberculosis. Sci Rep [Internet]. 2017;7:11948 Available from: http:\/\/www.nature.com\/articles\/s41598-017-10773-5.","journal-title":"Sci Rep [Internet]"},{"key":"604_CR50","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1073\/pnas.0900408106","volume":"106","author":"KS Voo","year":"2009","unstructured":"Voo KS, Wang Y-H, Santori FR, Boggiano C, Wang Y-H, Arima K, et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A. 2009;106:4793\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"604_CR51","doi-asserted-by":"publisher","unstructured":"Kachler K, Holzinger C, Trufa DI, Sirbu H, Finotto S. The role of Foxp3 and Tbet co-expressing Treg cells in lung carcinoma. Oncoimmunol [Internet]. Taylor & Francis; 2018;7:e1456612. Available from: https:\/\/doi.org\/https:\/\/doi.org\/10.1080\/2162402X.2018.1456612.","DOI":"10.1080\/2162402X.2018.1456612"},{"issue":"6","key":"604_CR52","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/ni.1731","volume":"10","author":"Meghan A Koch","year":"2009","unstructured":"Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol [Internet]. 2009;10:595\u2013602. Available from: http:\/\/www.nature.com\/doifinder\/https:\/\/doi.org\/10.1038\/ni.1731","journal-title":"Nature Immunology"},{"key":"604_CR53","first-page":"575","volume":"18","author":"JD Simmons","year":"2018","unstructured":"Simmons JD, Stein CM, Seshadri C, Campo M, Alter G, Fortune S, et al. Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection. Nat Rev Immunol [Internet]. Springer US. 2018;18:575\u201389 Available from: http:\/\/www.nature.com\/articles\/s41577-018-0025-3.","journal-title":"Springer US"},{"key":"604_CR54","first-page":"1","volume":"2015","author":"MV da Silva","year":"2015","unstructured":"da Silva MV, Massaro Junior VJ, Machado JR, Silva DAA, Castellano LR, Alexandre PBD, et al. Expression Pattern of Transcription Factors and Intracellular Cytokines Reveals That Clinically Cured Tuberculosis Is Accompanied by an Increase in Mycobacterium -Specific Th1, Th2, and Th17 Cells. Biomed Res Int [Internet]. 2015;2015:1\u201314 Available from: http:\/\/www.hindawi.com\/journals\/bmri\/2015\/591237\/.","journal-title":"Biomed Res Int [Internet]"},{"issue":"3","key":"604_CR55","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/jmv.23810","volume":"86","author":"Alpana Singh","year":"2013","unstructured":"Singh A, Vajpayee M, Ali SA, Chauhan NK. Cellular interplay among Th17, Th1, and Treg cells in HIV-1 subtype \u201cC\u201d infection. J Med Virol [Internet]. 2014;86:372\u2013384. Available from: http:\/\/doi.wiley.com\/https:\/\/doi.org\/10.1002\/jmv.23810","journal-title":"Journal of Medical Virology"},{"key":"604_CR56","doi-asserted-by":"crossref","unstructured":"Lardy H, Kneer N, Wei Y, Partridge B, Marwah P. Ergosteroids II: Biologically active metabolites and synthetic derivatives of Dehydroepiandrosterone. Steroids [Internet] 1998;63:158\u2013165. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X97001591","DOI":"10.1016\/S0039-128X(97)00159-1"},{"key":"604_CR57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1006\/abbi.1997.9955","volume":"341","author":"V Bobyleva","year":"1997","unstructured":"Bobyleva V, Bellei M, Kneer N, Lardy H. The effects of the Ergosteroid 7-Oxo-dehydroepiandrosterone on mitochondrial membrane potential: possible relationship to thermogenesis. Arch Biochem Biophys [Internet]. 1997;341:122\u20138 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986197999550.","journal-title":"Arch Biochem Biophys [Internet]"},{"key":"604_CR58","doi-asserted-by":"publisher","unstructured":"Saheki T, Moriyama M, Kuroda E, Funahashi A, Yasuda I, Setogawa Y, et al. Pivotal role of inter-organ aspartate metabolism for treatment of mitochondrial aspartate-glutamate carrier 2 (citrin) deficiency, based on the mouse model. Sci Rep [Internet]. Springer US; 2019;9:4179. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1038\/s41598-019-39627-y","DOI":"10.1038\/s41598-019-39627-y"},{"key":"604_CR59","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.celrep.2012.10.009","volume":"2","author":"MM Kami\u0144ski","year":"2012","unstructured":"Kami\u0144ski MM, Sauer SW, Kami\u0144ski M, Opp S, Ruppert T, Grigaravi\u010dius P, et al. T cell activation is driven by an ADP-dependent Glucokinase linking enhanced glycolysis with mitochondrial reactive oxygen species generation. Cell Rep. 2012;2:1300\u201315.","journal-title":"Cell Rep"},{"issue":"2","key":"604_CR60","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","volume":"38","author":"Laura\u00a0A. Sena","year":"2013","unstructured":"Sena LA, Li S, Jairaman A, Prakriya M, Ezponda T, Hildeman DA, et al. Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling. Immunity [Internet]. Elsevier Inc.; 2013;38:225\u2013236. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.immuni.2012.10.020","journal-title":"Immunity"},{"issue":"4","key":"604_CR61","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.4049\/jimmunol.171.4.1816","volume":"171","author":"Radiah A. Corn","year":"2003","unstructured":"Corn RA, Aronica MA, Zhang F, Tong Y, Stanley SA, Kim SRA, et al. T cell-intrinsic requirement for NF-\u03baB induction in Postdifferentiation IFN-\u03b3 production and clonal expansion in a Th1 response. J Immunol [Internet] 2003;171:1816\u20131824. Available from: http:\/\/www.jimmunol.org\/lookup\/doi\/https:\/\/doi.org\/10.4049\/jimmunol.171.4.1816","journal-title":"The Journal of Immunology"},{"issue":"5","key":"604_CR62","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/eji.200636322","volume":"37","author":"Sharon\u2004A. McCracken","year":"2007","unstructured":"McCracken SA, Hadfield K, Rahimi Z, Gallery ED, Morris JM. NF-\u03baB-regulated suppression of T-bet in T cells represses Th1 immune responses in pregnancy. Eur J Immunol [Internet]. 2007;37:1386\u20131396. Available from: http:\/\/doi.wiley.com\/https:\/\/doi.org\/10.1002\/eji.200636322","journal-title":"European Journal of Immunology"},{"key":"604_CR63","doi-asserted-by":"crossref","unstructured":"Bal\u00e1zs Z, Nashev LG, Chandsawangbhuwana C, Baker ME, Odermatt A. Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11beta-hydroxysteroid dehydrogenase 1. Mol Cell Endocrinol [Internet]. 2009 [cited 2013 may 1];301:117\u2013122. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19010388.","DOI":"10.1038\/npre.2008.2430.1"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-019-0604-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12929-019-0604-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-019-0604-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:41:59Z","timestamp":1609807319000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-019-0604-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["604"],"URL":"https:\/\/doi.org\/10.1186\/s12929-019-0604-z","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"26 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was carried out in line with the World Medical Association Declaration of Helsinki and approved by the Ethics Committee of Fundaci\u00f3n Hu\u00e9sped, Buenos Aires, Argentina. Written informed consent was provided by all the participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}